Impact and Sequelae of High Ventilatory Drive in Critically Ill COVID-19 Patients

Last updated: May 3, 2022
Sponsor: Corporacion Parc Tauli
Overall Status: Active - Recruiting

Phase

N/A

Condition

Mild Cognitive Impairment

Respiratory Failure

Lung Injury

Treatment

N/A

Clinical Study ID

NCT05363332
HighDrive COVID-19
  • Ages > 18
  • All Genders

Study Summary

Critically ill COVID-19 patients with acute respiratory failure, in the intensive care unit (ICU), often feature high respiratory drive, determining large inspiratory efforts resulting in high pressures and global and regional over-distention, leading to lung injury. SARS-CoV-2 neurotropic-penetration in control centers in medulla oblongata might contribute to dysregulation and to excessively high respiratory drive observed in these patients. These pathophysiological conditions may often lead to the development of patient-ventilator asynchronies in aptients under mechanical ventilation, again leading to high tidal volumes and increased lung injury. These phenomena can contribute to prolonged duration of mechanical ventilation and ICU length of stay, but also can result in long term adverse outcomes like emotional/psychological and cognitive sequelae. All them compromising the quality of life of critically ill survivors after ICU discharge.

The investigators will conduct a multicenter study in adult critically ill COVID-19 patients with hypoxemic respiratory failure, aiming to: 1) characterize incidence and clustering of high respiratory drive by developing algorithms, 2) apply artificial intelligence in respiratory signals to identify potentially harmful patient-ventilator interactions, 3) characterize cognitive and emotional sequelae in critically ill COVID-19 survivors after ICU discharge and 4) identify sets of genes and transcriptomic signatures whose quantified expression predisposed to asynchronies and cognitive impairment in critically ill COVID-19 patients.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Adults patients with hypoxemic respiratory failure.
  • Admitted to ICU.
  • Mechanical ventilation or high flow nasal cannula

Exclusion

Exclusion Criteria:

  • Neurologic patients with brainsteam affection.

Study Design

Total Participants: 126
Study Start date:
November 15, 2021
Estimated Completion Date:
November 15, 2024

Connect with a study center

  • Candelaria De Haro

    Sabadell, Barcelona 08208
    Spain

    Active - Recruiting

  • Fundació Althaia

    Manresa,
    Spain

    Active - Recruiting

  • Hospital Universitario Central de Asturias

    Oviedo,
    Spain

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.